Pages that link to "Item:Q5459586"
From MaRDI portal
The following pages link to A Parallel Phase I/II Clinical Trial Design for Combination Therapies (Q5459586):
Displaying 9 items.
- Bayesian phase I/II adaptively randomized oncology trials with combined drugs (Q641145) (← links)
- Continual reassessment method for partial ordering (Q2893418) (← links)
- A Latent Contingency Table Approach to Dose Finding for Combinations of Two Agents (Q3183236) (← links)
- A multi‐source adaptive platform design for testing sequential combinatorial therapeutic strategies (Q4628381) (← links)
- Semiparametric Dose Finding Methods for Partially Ordered Drug Combinations (Q5041342) (← links)
- Making Efficient Use of Patients in Designing Phase III Trials Investigating Simultaneously a Set of Targeted Therapies with Different Targets (Q5122882) (← links)
- A Three-Stage Bayesian Adaptive Phase I/II Design and Simulation Studies (Q5417921) (← links)
- Phase 2 and 3 Combination Designs to Accelerate Drug Development (Q5754831) (← links)
- Dual-agent dose-finding in phase I clinical trial -- an extension of rapid enrollment design (Q6652600) (← links)